The First GMO Animal Was Just Approved. But You Probably Won’t be Eating It Anytime Soon.

<a href="http://www.shutterstock.com/pic-91610936/stock-photo-fresh-salmon-with-spices.html?src=HpLjfWnnBNBTMcc2SzPxNw-1-3">HL Photo</a>/Shutterstock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Since the mid-1990s, a US company called AquaBounty Technologies—now partially owned by the synthetic biology company Intrexon—has been trying to get the Food and Drug Administration to approve a salmon variety genetically engineered to put on weight faster. On Thursday, the FDA finally did so. Theoretically, at least, US retailers can now stock the fast-growing fish, and they don’t have to label it.

The only GM salmon that makes it onto US store shelves will come from eggs produced in Prince Edward Island, which will be shipped and raised in Panama, only to be shipped back to North America as filets.

But don’t expect it to take over the seafood counter of your local supermarket anytime soon. We import about two-thirds of the salmon we eat, the great bulk of it grown on large farms in Chile, Canada, and Norway. But the FDA is hyper-specific about where AquaBounty’s engineered salmon can be grown:

The AquAdvantage Salmon may be raised only in land-based, contained hatchery tanks in two specific facilities in Canada and Panama. The approval does not allow AquAdvantage Salmon to be bred or raised in the United States. In fact, under this approval, no other facilities or locations, in the United States or elsewhere, are authorized for breeding or raising AquAdvantage Salmon that are intended for marketing as food to U.S. consumers.

Why the caution? Standard salmon farming takes place directly in the ocean in net cages. Escapes are inevitable. In areas like the North American west coast from California to Alaska—home to some of the globe’s last remaining wild salmon runs—escaped fast-growing salmon could out-compete and displace their wild peers. A highly detailed 2013 risk assessment from Canada’s Department of Fisheries and Oceans found that, without strict containment, the AquaAdvantage super-salmon presents a “high” risk to wild populations. 

So for now, until the FDA approves other facilities, the only GM salmon that makes it onto US store shelves will come from eggs produced in one approved facility on Canada’s Prince Edward Island, which will be shipped and raised into fish at another approved facility in Panama, only to be shipped back to North America as filets. That one facility in Panama is not likely to pose much competition to, say, Norway‘s vast salmon farms.

Meanwhile, the biotech-watchdog group the Center for Food Safety has vowed to sue the FDA to reverse the decision, claiming that “the review process by FDA was inadequate, failed to fully examine the likely impacts of the salmon’s introduction, and lacked a comprehensive analysis.”

Add limited supply and a legal challenge to the fact that several regional grocery powerhouses—including Kroger, Safeway, and HEB—have pledged not to sell GM salmon, and it seems unlikely that many consumers will be savoring AquaBounty’s bounty anytime soon.

 

 

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate